These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6510348)

  • 21. Comparison of the peripheral blood micronucleus test using flow cytometry in rat and mouse exposed to aneugens after single-dose applications.
    Cammerer Z; Elhajouji A; Kirsch-Volders M; Suter W
    Mutagenesis; 2007 Mar; 22(2):129-34. PubMed ID: 17284774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of pirimiphos-methyl, an organophosphorus insecticide on hematological parameters in albino rats.
    Rajini PS; Viswanatha S; Krishnakumari MK
    Indian J Exp Biol; 1987 Mar; 25(3):190-3. PubMed ID: 3666818
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hemocytes and the pathogenesis of malignant growth].
    Tereshchenko IP; Kashulina AP; Aleksandrova LM
    Vopr Onkol; 1983; 29(11):14-9. PubMed ID: 6649538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A combination of a thrombin inhibitor and dexamethasone prevents the development of experimental disseminated intravascular coagulation in rats.
    Elg M; Gustafsson D
    Thromb Res; 2006; 117(4):429-37. PubMed ID: 15869787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in the thymic factor level in rats with Jensen sarcoma and modification of the rate of tumor growth by administration of thymic hormone].
    Busse E; Rose H
    Z Exp Chir; 1981; 14(5):306-9. PubMed ID: 7199788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histidine-rich glycoprotein modulates the anticoagulant activity of heparin in human plasma.
    Lijnen HR; Van Hoef B; Collen D
    Thromb Haemost; 1984 Apr; 51(2):266-8. PubMed ID: 6740558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study on the antithrombotic effects of a synthetic thrombin inhibitor and of heparin in animal models.
    Hauptmann J; Barth A; Schönberger FP; Markwardt F
    Biomed Biochim Acta; 1983; 42(7-8):959-65. PubMed ID: 6651812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Growth inhibiting action of trenimon on a NMU induced sarcoma (author's transl)].
    Fuhse P; Bicker U; Tust R
    Arch Geschwulstforsch; 1974; 44(2):130-3. PubMed ID: 4451435
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessment of the role of neutrophils on the antitumor effect of TNFalpha in an in vivo isolated limb perfusion model in sarcoma-bearing brown Norway rats.
    Manusama ER; Nooijen PT; Stavast J; de Wilt JH; Marquet RL; Eggermont AM
    J Surg Res; 1998 Aug; 78(2):169-75. PubMed ID: 9733636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructural changes of secreting rat-incisor ameloblasts following administration of vincristine and vinblastine.
    Takuma S; Sawada T; Yanagisawa T
    J Dent Res; 1982 Dec; Spec No():1472-8. PubMed ID: 6958704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells.
    Castellot JJ; Beeler DL; Rosenberg RD; Karnovsky MJ
    J Cell Physiol; 1984 Sep; 120(3):315-20. PubMed ID: 6746751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ultrastructural changes in developing rat odontoblasts caused by administration of vinblastine (author's transl)].
    Miake Y
    Shikwa Gakuho; 1981 Oct; 81(10):1527-63. PubMed ID: 6952559
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of Eleutherococcus on the functional status of the anticoagulation system in older animals].
    Bazaz'ian GG; Liapina LA; Pastorova VE; Zvereva EG
    Fiziol Zh SSSR Im I M Sechenova; 1987 Oct; 73(10):1390-5. PubMed ID: 3428427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biochemical blood serum indices after the combined effect of UHF hyperthermy and x-ray radiation on animal tumors].
    Ul'ianenko SE; Surinov BP; Karpova NA
    Med Radiol (Mosk); 1981 May; 26(5):29-32. PubMed ID: 7242279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.